Navigation Links


firm at Biology News

LUCA technologies confirms real-time methane generation

Luca Technologies LLC today announced that its researchers have confirmed the presence of a resident, methane-generating community of microorganisms ("microbial consortium") in substrate samples taken from the 110,000 acre Monument Butte oilfield located in North Eastern Utah. This site represents the latest in a series of active "GeobioreactorsTM" that Luca Technologies has identified since its...

Oldest cranial, dental and postcranial fossils of early modern European humans confirmed

The human fossil evidence from the Mladec Caves in Moravia, Czech Republic, excavated more than 100 years ago, has been proven for the first time, through modern radiocarbon dating, to be the oldest cranial, dental and postcranial assemblage of early modern humans in Europe. A team of researchers from the Natural History Museum in Vienna, from the University of Vienna in Austria and from t...

NCI Researchers Confirm the Effectiveness of Immunotherapy Approach to Treating Melanoma

A team of researchers, led by Steven A. Rosenberg, M.D., at the National Cancer Institute, part of the National Institutes of Health, have found that patients with advanced melanoma who had not responded to previous therapies experienced a significant reduction in the size of their cancers as a result of receiving a new immunotherapy. This immunotherapy consisted of a combination of chemotherapy...

Confirmation of human protein interaction data by human expression data

As the brain develops, neurons reach out helter-skelter forming new connections, only a small number of which take hold. How the brain chooses which connections to keep and which to prune back appears to be governed by which branches have the most electrical activity—a finding that could help to explain how early experiences guide brain development. The work, published in the April 21 issu...

Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels

A team of scientists has discovered three molecules –?from a search of 58,000 compounds –?that appear to inhibit a key perpetrator of Alzheimer's disease. Ken Kosik, co...

More>>

firm at Biology Products
firm at Biology Technology

Madison firm provides $200K in capital to tech companies

MDC said it has closed on loans in that amount to C5-6 Technologies, Inc., a biofuels spin off of , and to <a...

Massachusetts firm to buy UW spinoff Bone Care for $600 million

Bone Care and Genzyme, a 24-year-old company with annual revenues of more than $2 billion and almost 7,000 employees w...

Two Milwaukee finance IT firms agree to exchange check images

Fiserv is an IT service provider claiming 4,000 financial clients. E...

British, Wisconsin firms explore life-science opportunities together

"We're looking for companies with complimentary products or complimentary technologies," said Frank Phillips, vice consul for the <a href="http://www.brit...

Confirming gene silencing mechanism by pGFP/GFP22 siRNA co-transfection

In addition to the specificity andefficiency of an siRNA sequencefor a target gene, which are ofhigh importance in post-transcriptionalgene silencing (PTGS), thedelivery of siRNA into cells is crucial.An efficient method to optimizetransfection and gene silenci...

More>>

firm at Medicine News

Multi billion-dollar suit filed against cell phone firm for causing brain tumours

In the United States of America, a lawyer- Peter Angelos, who won millions of dollars as compensation from the tobacco industry in Maryland, has announced that he is dragging Vodafone to court in a billion dollar suit. He is claiming compensation to cell phone users who are said to have developed brain tumours after using the instruments made by Verizon wireless. This case has raised eyeb...

Old theory of adaptation confirmed by new study

The adaptation theory that came up in 1971 argued that people react to good and bad events in their life, but they eventually return to a stable level of well-being. Researchers from Michigan State University, University of Illinois at Urbana-Champaign, France and England confirmed this theory based on a study conducted to evaluate the effects of marital transitions on life satisfaction....

First Human Bird-Flu Death Confirmed In China

China has officially confirmed its first human death from bird flu - a 24-year-old farmer from the eastern province of Anhui. The woman became sick after an outbreak of bird flu among poultry in her village in Zongyang county and died Nov 10, // the health ministry said, according to a report Thursday by the state-run Xinhua news agency. It is likely, however, that the woman'...

Drug Firm Offers to Donate Smallpox Vaccine

There is no treatment for smallpox, which kills about 30% of its victims and leaves others covered in sores. But giving a vaccine within days of exposure can protect against illness. A French drug company offered to donate up to 90 million doses of decades-old smallpox vaccine and the United States said it would accept the supplies if they are still effective against the deadly disease. /...

SARS research confirms link to animals

Chinese scientists compared the genetic makeup of viral particles isolated from humans with SARS with a virus found in wild animals recently captured //and being held in a retail food market. The animals were found to have a corona virus that was 99.8 percent genetically identical to a virus that causes severe acute respiratory syndrome, or SARS, in humans. Their findings sugges...

More>>

firm at Medicine Products

Pathfinder Chlamydia Culture Confirmation Test

Description:The Pathfinder Chlamydia Culture Confirmation provides clear and reliable staining of intracellular inclusions (elementary bodies and reticulate bodies) in tissue culture. The monoclonal antibody used in this kit is directed against the Chlamydia lipopolysaccharide....
Company:Bio-Rad Laboratories

BD Affirm™ VPIII Microbial Identification Test

Description:The Affirm™ VPIII tests RNA probe technology offers a dependable, rapid means toward early identification and treatment of patients suffering from these pathogens....
Company:BD Diagnostic Systems

Sanochemia Fluorognost HIV-1 IFA Confirmation Assay

Description:Donor Screening, Supplemental Confirmatory (Western Blot): The assay uses immortalized human T-cells which express HIV-1 antigens on their surface. The cells are fixed to the surface of an IFA glass slide. Fixed, uninfected T-cells are provided as a control. When a serum or plasma sample with HIV- I antibodies comes in contact with the HIV-1 antigens on the slide, antigen/antibody binding takes p...
Company:Sanochemia

Murad® Firm and Tone Serum For Cellulite and Stretch Mark Management

Description:Minimizes imperfections and reduces the visible appearance of cellulite and stretch marks. This formula refines uneven skin texture and improves skin firmness and elasticity to leave you with skin you'll be proud to show off....
Company:Murad, Inc.

6-Acetylmorphine Confirmation/Quantitation, Urine

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

More>>

firm at Medicine Technology

Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis

LEVERKUSEN, Germany - Biofrontera AG (DSE: B8F) announces todaythat it has received very positive results in the dose finding partof its phase IIb/III clinical trial started in autumn 2006. BF-200ALA, a gel that combines the active substance 5-aminolevulinic acid(ALA) with the nanoemulsion BF-200, was strongly and significantlysuperior to placebo in the treatment of actinic keratosis. BF-...

YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy

MISSISSAUGA, ON, July 09, 2007 /PRNewswire-FirstCall/ - YMBioSciences Inc. , an oncology company that identifies, developsand commercializes differentiated products for patients worldwide,today announced that a study presented by investigators from KinkiUniversity School of Medicine and Kyoto University at the 11thmeeting of The Japanese Association for Molecular Target Therapy ofCancer...

Publication Confirms that EpCAM, the Target for Two of Micromet's Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers

BETHESDA, Md., June 26, 2007 /PRNewswire-FirstCall/ -- Micromet,Inc. , a biopharmaceutical company focusing on the development ofnovel, proprietary antibody-based products for cancer, inflammatoryand autoimmune diseases, announced that a study published recentlyin the Proceedings of the National Academy of Sciences (1) supportsthe findings of several other studies that EpCAM (CD326), whic...

MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy

BOTHELL, WA – June 25 – MediQuest Therapeutics,Inc., a specialty pharmaceutical company focused on developingtherapies for inflammatory and infectious diseases, today announcedthe completion of its confirmatory phase III study of Vascana– a topical formulation designed to treat Raynaud’sDisease. The study met its primary end point and demonstrated statistica...

New Data Confirms Significant Improvement of Disease Signs and Symptoms in Patients with Rheumatoid Arthritis

Second Multinational Phase III Study Provides Further Evidence ofthe Significant Role of IL-6 Receptor Inhibition in the Treatmentof Rheumatoid Arthritis BASEL, Switzerland, June 6, 2007-Roche announced today thatToward (1), the second multinational phase III Actemra(tocilizumab) study, successfully reached its primary endpoint andshowed that a greater proportion of patients treated with...

More>>

Other TagsBODIBODIBODIBODIBODI
(Date:7/25/2008)... The Retina Group of New York will present a...r degeneration especially designed for seniors. Th...ibrary at 116 Merritts Road, Farmingdale, NY 11735...ce is free and refreshments will be provided. The ...0. , Hicksville and Haupp...
(Date:7/25/2008)... The Drug Information Association (DIA) and ...he Critical Path Initiative (CPI) on the Move: Com...da, MD) and the Critical Path Transporter Workshop... Horsham, PA (PRWEB) July 25, 2005-- T...ociation (DIA)] and the Food and Drug Administrati...
(Date:7/25/2008)... Columbus-based law firm represents Pickerin...urchased at Columbus-area Kroger store , ...25, 2008 -- http://www.donaheyohioinjurylawyers.c...sonal injury law firms in central Ohio, has filed ...rt (Case No. 08CV9804) against The Kroger Co., in ...
(Date:7/24/2008)... Hoag to lease hospital facility on Sand Can...h, CA (Vocus) July 24, 2008 -- Hoag Memorial Hospi..., Inc. (NYSE: HCP), a Real Estate Investment Trust...-bed hospital facility on Sand Canyon Avenue near ...lity is currently operated by Tenet Healthcare Cor...
Breaking Medicine News(10 mins):Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2Health News:Hoag Hospital Announces Agreement to Open Irvine Campus 2
(Date:7/25/2008)...niversity of Houston department of health and huma...of Second Life (SL) thanks to grants from the UH F...he Network Culture Project of the University of So...on. , "These funds will allow our faculty to sta...udents and our community," said Charles Layne, pro...
(Date:7/25/2008)...ALO, N.Y. -- Children born with hydrocephalus, or ... drain the fluid away from the brain to reduce har..., the rate of shunt infection in children is very ...ing the child through another surgery to replace t...ential additional neurological complications and a...
(Date:7/24/2008)...cal food shortages and growing demand for bio-fuel...ices rank among the greatest threats today to the ...mers and developers look for new areas for agricul...However, resisting pressures to convert wetlands i...e a suite of services essential to humanity, inclu...
(Date:7/24/2008)...es embedded with a telescope promise to make it ea...do other activities requiring sharper distance vis...scribe the advantages of these innovative glasses ...e May/June issue of Journal of Biomedical Optics ... , "This new design has several advantages," sa...
Breaking Biology News(10 mins):Second Life a first for UH department of health and human performance 2Antimicrobial sutures reduce infections in brain shunt surgery, study finds 2Rising energy, food prices major threats to wetlands as farmers eye new areas for crops 2Rising energy, food prices major threats to wetlands as farmers eye new areas for crops 3Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3Olympus Announces 2008 Winners of Olympus Innovation Awards 14936 1Olympus Announces 2008 Winners of Olympus Innovation Awards 14936 2Olympus Announces 2008 Winners of Olympus Innovation Awards 14936 3Olympus Announces 2008 Winners of Olympus Innovation Awards 14936 4HealthMEDX Partners With Silverchair Learning Systems 14932 1HealthMEDX Partners With Silverchair Learning Systems 14932 2BARACLUDE 28R 29 28entecavir 29 Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside naive Chronic 1582 1BARACLUDE 28R 29 28entecavir 29 Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside naive Chronic 1582 2BARACLUDE 28R 29 28entecavir 29 Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside naive Chronic 1582 3BARACLUDE 28R 29 28entecavir 29 Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside naive Chronic 1582 4BARACLUDE 28R 29 28entecavir 29 Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside naive Chronic 1582 5BARACLUDE 28R 29 28entecavir 29 Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside naive Chronic 1582 6Obese Women Less Likely to Be Tested for Some Cancers 14930 1Obese Women Less Likely to Be Tested for Some Cancers 14930 2
Other Contentsdraindraindraindraindraindraindraindrowsinessdrowsinessdressingdressingdressingdrowningdrowningingestioningestioningestioningestioningestioningestionaddictionaddictionaddictionaddictionaddictionaddictiondrydrydrydrydrydrydrydrydryduodenalduodenal